Patient Reported Outcomes from research to clinical practice. Opportunities and future challenges-Reference-Cited by-同舟云学术

Patient Reported Outcomes from research to clinical practice. Opportunities and future challenges

Published:2023-04-18 Issue: Volume:10 Page:60-63
ISSN:2465-2628
Container-title:AboutOpen
language:
Short-container-title:abtpn

Author:

Iannelli Elisabetta

Abstract

PROs, highly considered tools for the personalization of therapies and for research, are still scarcely used in clinical practice. Patient organizations played an important role in the validation process of these tools and are engaged in their dissemination and development.

Publisher

Aboutscience Srl

Subject

Materials Chemistry

Reference17 articles.

1. Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007;57(5):278-300. https://doi.org/10.3322/CA.57.5.278 PMID:17855485

2. Basch E, Snyder C, McNiff K, et al. Patient-reported outcome performance measures in oncology. J Oncol Pract. 2014;10(3):209-211. https://doi.org/10.1200/JOP.2014.001423PMID:24756142

3. Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244. https://doi.org/10.1093/jnci/dju244 PMID:25265940

4. Di Maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910-915. https://doi.org/10.1200/JCO.2014.57.9334 PMID:25624439

5. Basch E, Deal AM, Dueck AC, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017;318(2):197-198. https://doi.org/10.1001/jama.2017.7156 PMID:28586821